END-OF-DOSE DETECTION IN NEBULIZERS
20210187209 · 2021-06-24
Assignee
Inventors
- Joseph Grehan (County Galway, IE)
- Michael CASEY (County Galway, IE)
- Shaun Porter (County Galway, IE)
- Niall Smith (Scotland, GB)
Cpc classification
A61M11/00
HUMAN NECESSITIES
B05B15/14
PERFORMING OPERATIONS; TRANSPORTING
B05B12/081
PERFORMING OPERATIONS; TRANSPORTING
A61M2205/3317
HUMAN NECESSITIES
B06B1/0253
PERFORMING OPERATIONS; TRANSPORTING
B05B17/0646
PERFORMING OPERATIONS; TRANSPORTING
International classification
A61M11/00
HUMAN NECESSITIES
B05B15/14
PERFORMING OPERATIONS; TRANSPORTING
B05B17/00
PERFORMING OPERATIONS; TRANSPORTING
B05B17/06
PERFORMING OPERATIONS; TRANSPORTING
Abstract
A digital processor of a nebulizer controller controls and monitors drive current (I) applied to an aperture plate. The drive current is detected as a series of discrete values at each of multiple measuring points, each having a particular drive frequency The processor in real time calculates a slope or rate of change of drive current with frequency and additionally determines a minimum value for drive current leading up to the peak value. The processor uses both the value of the minimum drive current during the scan and also the maximum slope value to achieve reliable prediction of end of dose, when the aperture plate becomes dry.
Claims
1-19. (canceled)
20. A nebulizer, comprising: a vibrating aperture plate; an actuator; and an aperture plate drive circuit having a controller, wherein the controller is configured to: measure drive current to the aperture plate; detect end-of-dose based on a minimum value of the drive current; and upon detection of end-of-dose, automatically stop operation of the actuator.
21. The nebulizer of claim 20, wherein the controller is further configured to detect the end-of-dose based on the minimum value of the drive current and a maximum rate of change of the drive current.
22. The nebulizer of claim 21, wherein the controller is further configured to detect the end-of-dose based on a ratio of the maximum rate of change and the minimum value of the drive current.
23. The nebulizer of claim 20, wherein the controller is configured to measure the drive current during a scan across a plurality of drive frequencies.
24. The nebulizer of claim 23, wherein the plurality of drive frequencies includes a drive frequency range of 128 kHz to 165 kHz.
25. The nebulizer of claim 23, wherein the controller is configured to initiate the scan in response to a trigger of possible end-of-dose.
26. The nebulizer of claim 25, wherein the trigger is a short scan with a smaller number of measuring points and which detects a change of drive current above a threshold.
27. The nebulizer of claim 26, wherein the threshold is above 5 mA.
28. The nebulizer of claim 20, wherein the minimum value of the drive current for end-of-dose corresponds to approximately less than 30% of a minimum value of the drive current for a wet state of the aperture plate.
29. A method of operation of a controller of a nebulizer comprising a vibrating aperture plate, an actuator, and an aperture plate drive circuit, the method comprising: measuring drive current to the aperture plate; detecting end-of-dose based on a minimum value of the drive current; and upon detection of end-of-dose, automatically stopping operation of the actuator.
30. The method of claim 29, wherein the detecting the end-of-dose includes detecting the end-of-dose based on the minimum value of the drive current and a maximum rate of change of the drive current.
31. The method of claim 30, wherein the detecting the end-of-dose includes detecting the end-of-dose based on a ratio of the maximum rate of change and the minimum value of the drive current.
32. The method of claim 29, wherein the measuring the drive current includes measuring the drive current during a scan across a plurality of drive frequencies.
33. The method claim 32, wherein the plurality of drive frequencies includes a drive frequency range of 128 kHz to 165 kHz.
34. The method of claim 32, further comprising initiating the scan in response to a trigger of possible end-of-dose.
35. The method of claim 34, wherein the trigger is a short scan with a smaller number of measuring points and which detects a change of drive current above a threshold.
36. The method of claim 35, wherein the threshold is above 5 mA.
37. The method of claim 29, wherein the minimum value of the drive current for end-of-dose corresponds to approximately less than 30% of a minimum value of the drive current for a wet state of the aperture plate.
38. A non-transitory computer readable medium comprising software code to perform a method of operation of a controller of a nebulizer comprising a vibrating aperture plate, an actuator, and an aperture plate drive circuit, when executing on a digital processor, the method comprising: measuring drive current to the aperture plate; detecting end-of-dose based on a minimum value of the drive current; and upon detection of end-of-dose, automatically stopping operation of the actuator.
39. The non-transitory computer readable medium of claim 38, wherein the detecting the end-of-dose includes detecting the end-of-dose based on the minimum value of the drive current and a maximum rate of change of the drive current
Description
DETAILED DESCRIPTION OF THE INVENTION
Brief Description of the Drawings
[0053] The invention will be more clearly understood from the following description of some embodiments thereof, given by way of example only with reference to the accompanying drawings in which:—
[0054]
[0055]
[0056]
[0057]
DESCRIPTION OF THE EMBODIMENTS
[0058] A nebulizer of the invention has a vibrating aperture plate, a mounting for the plate, an actuator such as a piezoelectric element, and an aperture plate drive circuit having a controller with a digital processor. The digital processor is programmed to drive the aperture plate so that liquid medication is aerosolized. It predicts when the liquid medication has been consumed, with the plate becoming dry. This is referred to as “end-of-dose (EOD)”.
[0059] Referring to
[0060] For aperture plate drive current measurement, the processor measures a voltage across a fixed shunt resistor. This provides enough information to determine the impedance of the nebulizer. This is essentially a current measurement.
[0061] When operating close to anti-resonance more current is consumed nebulizing in the wet state than in the dry state. During the scan of drive current values across multiple frequencies the minimum drive current is identified and the current consumption for this point is recorded.
[0062] The slope differential is also determined during the scan. The drive current (or “current consumption”) at each measuring point is compared to the current drawn at the previous measuring point. The software routine executed by the processor records the maximum differential slope (“MDS”) of drive current measurements found across the full frequency range.
[0063] As more power is necessary to drive the aperture plate in its wet state, the presence of liquid on the plate results in a higher current than the dry state. In addition to this, the presence of liquid has a dampening effect, resulting in a small rate of change of current across the frequencies in the wet state. On the other hand, in the dry state the MDS differential is a large value. These attributes are illustrated in the plots of
[0064] Following the wet state plot of
[0065] On the other hand, for the dry state plot the current dips to a minimum which is only about 30% of that for the wet state. Also, the maximum slope (“Dry MDS”) is much higher, by a factor of about 4 when compared to the wet state maximum slope.
[0066] It has been found that a particularly reliable and accurate end-of-dose determination can be made by employing both the scan's minimum current and MDS during the scan. In one embodiment the algorithm is:
EOD_Value=(max.slope/min.I)*1000 [0067] where, [0068] max.slope is the scan's maximum slope value, [0069] 1000 is a fixed number to scale the value and being selected for ease of computations, and to allow use of low-cost processor, and [0070] min.I is drive current at the anti-resonant point, which is the preceding minimum.
[0071] As shown in
[0072]
[0073] The full EOD algorithm (
1. 137 KHz/128 KHz (Operating Frequency)
[0074] 2. 140 KHz (2.sup.nd frequency where nebulization is not interrupted)
[0075] Referring to
Configuration Parameters
[0079]
TABLE-US-00001 SCAN_FREQ (frequency values for each 137 KHz to 156 KHz measuring point) OPERATING_FREQ 137 KHz SCAN_VOLTS 10 V RUN_VOLTS 12 V EOD_CUTOFF 174
[0080] The EOD_CUTOFF value was determined from a sample size of 175 pieces, it was chosen as the mid-point between the max wet and the min dry values. Please refer to
[0081] The addition of utilizing the minimum currents in the calculation of an EOD_value provides a more robust method of determining the wet/dry state of the nebulizer. These minimum currents correspond to the anti-resonant frequency of the aperture plate, and this anti-resonant frequency may differ from the wet to dry state, due to the presence of liquid on the aperture plate
[0082] Also, the anti-resonance current when the aperture plate is wet will be higher than the anti-resonance current when it is dry as additional energy is required to displace the liquid in the wet state, which in turn translates to an additional electrical power requirement.
[0083] In summary, the main function of full end-of-dose scan is to determine the status of the plate. The scan finds the maximum rate of change in current found between successive frequencies (maximum slope). Another function is to determine the minimum current, that drawn at anti-resonance. The ratio of the max.slope/min.current is used to determine the status of the plate. This value is much greater when the plate is dry than when it is wet, with a much greater differential than when only using the slope value.
[0084] When a direct comparison to the prior end-of-dose method described in WO2015/010809 is made, it can be seen that the method of the invention has greater than 75% improved divergence between the wet and dry groupings, as shown in
[0085] By providing significantly more accurate and reliable indications of end of dose, the invention helps to achieve a longer useful lifetime of an aperture plate.
[0086] Also, the invention helps to provide a nebulizer which caters much better with variation of parameters associated within large scale manufacture. Despite excellent manufacturing practice, small variations in parameters exist within all the stages of manufacture, and when these variations are combined, they can lead to considerable differences in the operating parameters of a nebulizer. The extent of divergence in the calculated values between wet and dry states, ensures that EOD detection accuracy will be achieved every time.
[0087] Also, in the case, of over-moulded nebulizers, the complete vibratory actuator, including the piezo-electric element, is encapsulated to allow easier cleaning of the nebulizer after use. This however causes a restriction of movement, which significantly reduces the capability of the processor to identify the presence of liquid on the aperture plate. The invention circumvents this restraint due to its extent of sensitivity to the aperture plate becoming dry.
[0088] Nebulizers of the invention also provide several therapeutic benefits for patients such as those suffering from Cystic Fibrosis (“CF”), who need to spend long periods taking medication, often every day. Nebulizers for this application are typically over-moulded, and because the processor according to the invention provides instantaneous feedback on dose completion which, in the case of children, means less dosing time and also much less monitoring/assistance requirements from parents. This is especially so if the controller is configured to shut down the nebulizer and so extend the life of the nebulizer aperture plate. Also, by shutting off at the end of the delivery of medication, as identified by the end of dose, the nebulizer will dramatically improve the capability of battery powered devices to deliver longer periods on a single charge/set of batteries.
[0089] The invention is not limited to the embodiments described but may be varied in construction and detail. As an alternative to directly measuring drive current at each of the measuring points, it is envisaged that it may be indirectly measured by for example measuring impedance of the aperture plate. In this specification, where it is stated that drive current is measured, this may be either directly or indirectly. The frequency range may be within a different range, but is preferably within 128 kHz and 165 kHz, and more preferably about 137 kHz and 156 kHz.